Robotic and Mini‑Invasive Transplants Signal a New Era for Heart and Lung Surgery
A fully robotic heart transplant was performed in the United States [2], and the nation’s first minimally invasive double‑lung transplant was performed in the United States [3]. At the same time, researchers uncovered a molecular clue that may help lungs recover after the inevitable injury that occurs when blood flow is restored [1].
Key takeaways
- A fully robotic heart transplant was performed in the United States [2].
- A Huntington Beach patient received the first minimally invasive double‑lung transplant, using small incisions instead of a traditional sternotomy [3].
- A new study identified a lysosome‑focused macrophage (a type of immune cell) that may aid lung repair after ischemia‑reperfusion injury, the damage caused when blood returns to the transplanted organ [1].
- Increasing cathepsin L activity enhanced enzymatic function and reduced cytokine responses in macrophages [1].
Robotic heart surgery breaks new ground
Surgeons completed a heart transplant using only robotic arms and tiny ports, and the procedure was broadcast on a national morning show [2].
Mini‑invasive double‑lung transplant offers another option
A man in Huntington Beach received a double‑lung transplant through a minimally invasive approach [3].
Molecular insights may improve lung graft healing
Lung transplants often suffer from primary graft dysfunction (PGD), a form of ischemia‑reperfusion injury (IRI) that damages the organ when blood flow returns after the transplant [1]. Researchers examined paired lung biopsies from donors and recipients, integrating proteomic data with single‑cell analysis [1]. They discovered a transitional macrophage that expressed many lysosome‑related genes, calling it a lipid‑associated macrophage (LAM) [1]. The enzyme cathepsin L (CTSL) stood out as a key player in this reparative state [1]. Experiments showed that increasing CTSL boosted its enzymatic activity, partially restored normal macrophage function, and reduced cytokine production linked to IRI [1]. The study identified CTSL as a candidate lysosomal effector in reparative macrophages [1]. The study involved both donor‑resident macrophages and recipient‑recruited monocytes, indicating a shared immune response across the graft‑host interface [1].
